Latest News

Journal Articles

Autoimmune

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Multiple sclerosis research suggests a neuroprotective benefit following resistance training

Parkinson’s is partly an autoimmune disease, new study states

Cerebrovascular disease

Stroke Administrative Severity Index: using administrative data for 30-day poststroke outcomes prediction

Inflammation in brain blood vessels leads to gastrointestinal failure

Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy

CNS/PNS/SNS

Enter the Honeycomb maze: a new gold standard for spatial navigation?

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

Future biomaterials for enhanced cell–substrate communication in spinal cord injury intervention

Cognitive/neurodegenerative disorders

Is amyloid-beta transmissible?

Underexplored cause of dementia may be diagnosed with simple walking test

Alcohol use disorders are biggest risk factor for dementia, new study states

Demyelinating disease

The exciting field of neuro-repair in multiple sclerosis: an interview with Sarah I Sheikh

Advancing the understanding of progression in multiple sclerosis: an interview with Shibeshih Belachew

Monitoring nerve protein in blood tests may help predict multiple sclerosis (MS) flare-ups

Development and pediatrics

Epigenetics, opioids and immune regulation: interviews from SfN17

A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington’s disease

Could lithium chloride inhibit fetal alcohol syndrome-related brain damage?

Epilepsy and seizure

Reports of brain damage call a halt to Bellicum trials: industry news round-up

Could novel epileptic encephalopathy genes promote advances in treatment strategy?

NCTalks with Ali Rezai: changing lives through neuromodulation

Genetics

Epigenetics, opioids and immune regulation: interviews from SfN17

Is telomere length a biomarker of neurological disorders?

A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington’s disease

Headache

Latest erenumab trial signals hope for refractory migraine sufferers

Is there a link between the sodium concentration in cerebrospinal fluid and migraines?

Migraine attacks halved by antibody therapies

Immune disorders and inflammation

NCTalks at SfN17: Doris Doudet on Parkinson's, inflammation and the gut

Depression, anxiety, and stress severities in multiple sclerosis patients using injectable vs. oral treatments

Effect of exercise interventions on perceived fatigue in people with multiple sclerosis: synthesis of meta-analytic reviews

Infection

NCTalks at SfN17: Kijun Yoon gives a Zika update

SfN17: CRISPR and iPSCs – new techniques to study the brain

Infographic: The facts about Zika

Injury/trauma

First blood test for concussion assessment wins FDA approval

Risk of dementia may be increased for decades after traumatic brain injury

Spinal cord repair genes shared by lampreys and mammals

Movement disorders

Parkinson’s disease development may be influenced by calcium levels

LMTX drug shows promise for use in Parkinson’s disease therapy

The world’s first pluripotent stem cell-based trial for Parkinson’s disease: an interview with Russell Kern

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Repurposing of malaria drug to halt ALS disease progression

Neuropsychiatry

Antidepressants demonstrate superiority against placebos

Brain cell damage caused by heavy alcohol consumption could be reversed by new drug

Experimental autism drug balovaptan granted Breakthrough Therapy Designation

Oncology/tumor

Could Huntington’s disease act as an anti-cancer tool?

World Cancer Day: the year’s biggest breakthroughs in neuro-oncology

Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?

Pain

Epigenetics, opioids and immune regulation: interviews from SfN17

SfN17: Updates on stemming pain and understanding opioid abuse

NCTalks with Ali Rezai: changing lives through neuromodulation

Sleep

#NCIntroduces... sleep science

Better sleep works like a dream at reducing fear learning

Sleep research realizes the dream of understanding brain plasticity mechanisms